📜(R)-2-氧代噻唑烷-4-羧酸甲酯置于盐酸体系中,用 溶剂黄146 用作溶剂,化学反应生成丙半胱氨酸 参考文献:Total Synthesis Of (+)-Latrunculin A,An Ichthyotoxic Metabolite Of The Sponge Latrunculia Magnifica And Its C-15 Epimer 标题:Total Synthesis Of (+)-Latrunculin A,An Ichthyotoxic Metabolite Of The Sponge Latrunculia Magnifica And Its C-15 Epimer 摘要:Latrunculin A (1),An Ichthyotoxic Metabolite Of The Sponge Latrunculia Magnifica With Potent Inhibitory Action On Microfilament-Mediated Processes Involved In Cell Division,Was Synthesized Via A Convergent Approach. Construction Of A Major Segment Of The Latrunculin Backbone Was Accomplished By Means Of A Three-Component Coupling Of Aldehyde 24,Beta-Keto Ester 27,And Phosphonium Salt 26,Which Established The Conjugated Ez-Diene Moiety Of 31. The Thiazolidinone Subunit Of 1 Was Elaborated In The Form Of 39 From L-Cysteine And Was Linked To 35 Without Nitrogen Protection. Final Lactonization Of 47 Was Carried Out Using The Mitsunobu Protocol. A Parallel Sequence Employing The Epimeric Seco Acid 48 Produced 15-Epilatrunculin A. Doi:10.1021/jo00046A008
专利号:US-2024024489-A1 优先权日:2020-11-20 标 题:Protected disaccharides, their process of preparation and their use in the synthesis of zwitterionic oligosaccharides, and conjugates thereof 发明人:MULARD LAURENCE; DHARA DEBASHIS; PFISTER HELENE; PAOLETTI JULIE; PHALIPON ARMELLE; GUERREIRO-INVERNO CATHERINE 权利人:PASTEUR INSTITUT 摘要:The present invention provides zwitterionic oligosaccharides, in particular fragments of the surface polysaccharides from Shigella sonnei and Shigella sonnei conjugates comprising them. The present invention also provides protected disaccharides, their process of preparation and their use in the synthesis of zwitterionic oligosaccharides, and conjugates thereof, the disaccharide repeating unit of Shigella sonnei being: (I)
专利号:US-11834468-B2 优先权日:2017-07-03 标 题:Protected tetrasaccharides, their process of preparation and their use as transglucosylase acceptor substrates in the chemo-enzymatic synthesis of Shigella flexneri specific oligosaccharides 发明人:MULARD LAURENCE; LE HEIGET GUILLAUME; HU ZHAOHU; BAREL LOUIS-ANTOINE; ANDRE ISABELLE; MOULIS CLAIRE; REMAUD-SIMEON MAGALI; BARBE SOPHIE; BENKOULOUCHE MOUNIR; BEN IMEDDOURENE AKLI 权利人:PASTEUR INSTITUT; AGRONOMIQUE INST NAT RECH; INSTITUT NAT DES SCIENCES APPLIQUEES DE TOULOUSE; CENTRE NAT RECH SCIENT 摘要:The present invention provides protected tetrasaccharides, their process of preparation and their use in the synthesis of oligosaccharides, in particular fragments of O-antigens from Shigella flexneri, for example of serotype 1a, 1b, 2a, 2b, 3a, X, 4a, 4b, 5a, 5b, 7a or 7b.
专利号:US-5208249-A 优先权日:1992-08-20 标 题 :Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate 发明人:ROWE W BRUCE; GOLDBERG DENNIS I 权利人:CLINTEC NUTRITION CO 摘要:A method for stimulating the intracellular synthesis of glutathione comprising the step of administering to a mammal a therapeutically effective amount of an ester of 2-oxothiazolidine-4-carboxylate is provided.
专利号:US-7662401-B2 优先权日:2002-04-08 标 题 :Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase 发明人:MAHE YANN; MEYBECK ALAIN 权利人:OREAL 摘要:The present invention relates to the cosmetic or pharmaceutical use of an extract of a nonfruiting nonphotosynthetic filamentous bacterium in a composition containing a cosmetically or pharmaceutically acceptable medium, as an agent increasing the endogenous synthesis of superoxide dismutase, in particular for preventing and/or limiting the formation of free radicals and/or removing the free radicals present in cells; in addition, the invention relates to a composition comprising at least one extract of Vitreoscilla filiformis and lycopene.
专利号:US-6531608-B2 优先权日:1999-05-25 标题:Various thiol complexes, processes for their synthesis and clinical applications 发明人:PEARSON DON C; RICHARDSON KENNETH T 权利人:CHRONORX LLC 摘要:This invention relates to the synthesis of certain complexes of cysteine, N-acetylcysteine, N-(2-mercaptopropionyl)glycine, and L-2-oxothiazolidine-4-carboxylate and to the nutritional use of these and other related individual or complexed thiol-contributing glutathione predecessors. Clinical uses for these molecules and complexes in the beneficial modification of various physiological conditions and functions associated with aging, chronic glaucoma, diabetes mellitus, insulin resistance, macular degeneration, neurodegenerative diseases and vasoconstriction are described in particular.
专利号:EP-0501641-A1 优先权日:1991-02-26 标 题 :L-2-oxothiazolidine-4-carboxylate and glutathion esters for the treatment of hepatic diseases 发明人:TRIMBO SUSAN; GOLDBERG DENNIS I 权利人:CLINTEC NUTRITION CO 摘要:The use of a composition that stimulates the intracellular synthesis of glutathione for providing a composition for treating hepatic disease is provided. In an embodiment, composition, that is administered to a patient having hepatic disease, includes a compound chosen from the group consisting of: L-2-oxothiazolidine-4-carboxylate; glutathione esters; and thiazolidine-4-carboxylate analogs, in an amount sufficient to stimulate intracellular glutathione synthesis. The compound can be administered parenterally or enterally.
1: Patel JJ, Bourne LE, Thakur S, Farrington K, Gorog DA, Orriss IR, Baydoun AR. 2-Oxothiazolidine-4-carboxylic acid inhibits vascular calcification via induction of glutathione synthesis. J Cell Physiol. 2020 Sep 12. doi: 10.1002/jcp.30036. Epub ahead of print. 11(9):2063. doi: 10.3390/nu11092063. 3: Lewis SR, Pritchard MW, Thomas CM, Smith AF. Pharmacological agents for adults with acute respiratory distress syndrome. Cochrane Database Syst Rev. 2019 Jul 23;7(7):CD004477. doi: 10.1002/14651858.CD004477.pub3. 4: Künstler A, Kátay G, Gullner G, Király L. Artificial elevation of glutathione contents in salicylic acid-deficient tobacco (Nicotiana tabacum cv. Xanthi NahG) reduces susceptibility to the powdery mildew pathogen Euoidium longipes. Plant Biol (Stuttg). 2020 Jan;22(1):70-80. doi: 10.1111/plb.13030. Epub 2019 Jul 31. 11(1):147-160. doi: 10.1007/s12975-019-00707-w. Epub 2019 May 2.
合成参考文献
摘要:Acute Toxicity Data. Journal of the American College of Toxicology, Part B., 1(164), 1992 摘要:Fawcett JP, Schiller B, Jiang R, Moran J, Walker RJ. Supplementation with L-2-oxothiazolidine-4-carboxylic acid, a cysteine precursor, does not protect against lipid peroxidation in puromycin aminonucleoside-induced nephropathy. Exp Nephrol. 1996 Jul;4(4):248–52. 参考文献:10.1007/s001340050876 摘要:Walsh TS, Lee A. N-acetylcysteine administration in the critically ill. Intensive Care Med. 1999 May;25(5):432–4. doi: 10.1007/s001340050876. 参考文献:10.1007/s004080000071 摘要:Barrios R, Shi ZZ, Kala SV, Wiseman AL, Welty SE, Kala G, Bahler AA, Ou CN, Lieberman MW. Oxygen-induced pulmonary injury in gamma-glutamyl transpeptidase-deficient mice. Lung. 2001;179(5):319–30. doi: 10.1007/s004080000071. 参考文献:10.1096/fasebj.6.12.1521740 摘要:Taylor CG, Bauman PF, Sikorski B, Bray TM. Elevation of lung glutathione by oral supplementation of L-2-oxothiazolidine-4-carboxylate protects against oxygen toxicity in protein-energy malnourished rats. FASEB J. 1992 Sep;6(12):3101–7. doi: 10.1096/fasebj.6.12.1521740.